Cargando…
Towards a novel approach guiding the decision-making process for anticancer treatment in patients with advanced cancer: framework for systemic anticancer treatment with palliative intent
BACKGROUND: Weighing risks and benefits is currently the primary criterion for decisions regarding systemic anticancer treatment (SACT) in far advanced cancer patients, also in the modern immunotherapy- and molecular-targeted driven oncology. Decision aids rarely include substantially key concepts o...
Autores principales: | Ribi, K., Kalbermatten, N., Eicher, M., Strasser, F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9271509/ https://www.ncbi.nlm.nih.gov/pubmed/35597176 http://dx.doi.org/10.1016/j.esmoop.2022.100496 |
Ejemplares similares
-
Acupuncture as anticancer treatment?
por: Frączek, Paulina, et al.
Publicado: (2017) -
Anticancer treatments and photosensitivity
por: Sibaud, V.
Publicado: (2022) -
The spliceosome as target for anticancer treatment
por: van Alphen, R J, et al.
Publicado: (2009) -
The effect of clinical decision making for initiation of systemic anticancer treatments in response to the COVID-19 pandemic in England: a retrospective analysis
por: Clark, James J, et al.
Publicado: (2021) -
Anticancer therapies in specialized palliative care—a multicenter survey
por: Alt-Epping, B., et al.
Publicado: (2011)